Bedaquiline
In News Recently, the Indian Patent Office rejected Johnson & Johnson’s attempt to extend its monopoly on manufacturing Bedaquiline in India. About Bedaquiline is an oral medication used to treat active tuberculosis. it is particularly used to treat multi-drug-resistant tuberculosis (MDR-TB) It has a unique mechanism of action, targeting the adenosine triphosphate (ATP) synthase enzyme […]